BridgeMD
New treatment option for Respiratory Distress Syndrome, Newborn
Official title Echography-guided Surfactant THERapy (ESTHER) For Preterm Infants With Respiratory Failure
ClinicalTrials.gov ID: NCT06446453
What this study is testing
- What it's testing
- Point-of-care ultrasound (POCUS) is the use of ultrasound by the bedside provider in real time to answer a specific question and guide medical management. POCUS can be used to diagnose the severity of neonatal respiratory distress syndrome (RDS) through a lung ultrasound score.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 2
You may be able to join if
- The infant's parent/legal guardian can understand and willingly sign a written informed consent document for this study
- Birth gestational age between 27w0d-36w6d
- Diagnosis of respiratory failure secondary to RDS requiring respiratory support with non-invasive positive pressure ventilation
You likely can't join if
- Unable to obtain lung ultrasound between 1-2 hours of life
- Infants already intubated or received surfactant before the point of care lung ultrasound
- Infants born with congenital cardiac disease, congenital lung disease, or congenital facial/airway malformations
- Infants born with chromosomal abnormalities
- Infants with APGARs ≤ 5 at 10 minutes of life
- Infants requiring cardiopulmonary resuscitation or therapeutic hypothermia in the first 6 hours of life
The study team makes the final eligibility decision.
Where it's taking place
- Hartford, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 hours to 2 hours. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hartford, Connecticut, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.